跳至主要内容
临床试验/NCT02279264
NCT02279264Unknown不适用

Product Validation Study of RightSpot Infant pH Indicator for Rapid Bedside Verification of Proper Nasogastric (NG) Tube Placement in Newborn Intensive Care (NICU) Patients

RightBio Metrics1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2014年9月最近更新:
适应症

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
To determine the percentage of samples obtained by the RightSpot pH Indicator that could have been used to assist in determining proper placement of the NG tube prior to use. (% of collected samples vs. uncollected)

研究概览

简要总结

Objectives:

  1. To validate the accuracy of pH measurements of gastric fluid by comparing the readings from the RightSpot Infant pH Indicator to a standard clinically approved pH monitor
  2. To determine what percentage of time the RightSpot Infant pH Indicator could have been used to determine the proper placement of the NG tube prior to feedings
  3. To establish normative pH values for neonates

详细描述

RightBio Metrics has developed an indicator that rapidly checks gastric pH by aspirating gastric contents into the indicator through a nasogastric (NG) or orogastric (OG), causing a color change on the indicator. The color change represents various pH levels. Most Newborn Intensive Care Units require that NG/OG placement be confirmed after initial insertion and prior to any use. The purpose of this study is to validate the accuracy of pH measurement of gastric fluid by comparing the reading from the RightSpot Infant pH Indicator to a standard clinically approved pH monitor, and to determine what percentage of time the RightSpot Infant pH Indicator could have been used to determine the proper placement of the NG/OG tube prior to use. The gastric pH measurements will be analyzed to determine the normative pH values for neonates.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
24 Weeks 至 40 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Infants in the Newborn Intensive Care Unit with an NG Tube

排除标准

  • Infants with congenital or genetic abnormalities
  • Infants with gastroschesis
  • Infants with upper airway abnormalities
  • Infants receiving any supplement or medication know to alter pH gastric contents
  • Infants receiving Enfamil liquid human milk fortification
  • Infant who are NPO status

结局指标

主要结局

To determine the percentage of samples obtained by the RightSpot pH Indicator that could have been used to assist in determining proper placement of the NG tube prior to use. (% of collected samples vs. uncollected)

时间窗: 12 weeks

To determine the percentage of samples obtained by the RightSpot pH Indicator that could have been used in determining proper placement of the NG tube prior to use.(% of sample accuracy)

时间窗: 12 weeks

To compare the gastric pH measurement obtained from the RightSpot Indicator to the gastric pH measurement obtained from an approved pH monitor to determine the agreement and accuracy of the two modes of measurements.

时间窗: 12 weeks

The gastric pH measurements will be collected and analyzed to determine the normative pH values for neonates

时间窗: 12 weeks

次要结局

  • Adjusted gestational age at the time of testing(12 weeks)
  • Infants weight at the time of testing(12 weeks)
  • Gestation age at birth(12 weeks)
  • Residual amount (ml) at the time of testing(12 weeks)
  • Medications given which effect pH of gastric contents(12 weeks)
  • Time infant last ate(12 weeks)
  • pH reading from gastric secretions(12 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Product Validation Study of RightSpot Infant pH... | 临床试验